Legato Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$710K Sell
15,413
-16,777
-52% -$809K 0.06% 465
2026
Q2
$1.89M Buy
+32,190
New +$1.35M 0.16% 196
2024
Q1
– Sell
-44,218
Closed -$1.22M – 617
2023
Q4
$1.22M Hold
44,218
– – 0.16% 214
2023
Q3
$987K Sell
44,218
-2,095
-5% -$53.9K 0.14% 245
2023
Q2
$1.18M Buy
46,313
+12,352
+36% +$299K 0.16% 212
2023
Q1
$757K Buy
33,961
+8,297
+32% +$201K 0.14% 254
2022
Q4
$609K Buy
+25,664
New +$596K 0.12% 287

Other funds holding VCYT

Legato Capital Management's VCYT Position: Q3 2026 in Review

Legato Capital Management reduced its Veracyte (VCYT) stake by 52% in Q3 2026, selling an estimated $809K and leaving 15,413 shares worth $710K. The position accounts for 0.06% of the portfolio, ranked #465.

Legato Capital Management first reported a position in VCYT in Q4 2022 and has held it in 7 quarters since. The position peaked at $1.89M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Legato Capital Management held 15,413 shares of Veracyte worth $710K as of Q3 2026.
  • Legato Capital Management sold 16,777 Veracyte shares in Q3 2026, an estimated $809K.
  • Veracyte made up 0.06% of Legato Capital Management's portfolio in Q3 2026, its #465 holding.
  • Legato Capital Management first reported a position in Veracyte in Q4 2022 and has held it in 7 quarters since.
  • Legato Capital Management's Veracyte position peaked at $1.89M in Q2 2026.
  • 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Legato Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.